Markets

Health Care Sector Update for 04/10/2015: ARNA, VRTX, ANIP

Top Health-care stocks:

JNJ: +0.1%

PFE: -0.7%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were generally unchanged in pre-market trade Friday.

In health-care stocks news, Arena Pharmaceuticals ( ARNA ) and Eisai announced Friday the completion of two Phase 1 registrational clinical trials that demonstrate the bioequivalence of an investigational once-daily extended release form of lorcaserin -- a weight-loss treatment -- as compared to the twice-daily immediate release formulation of Belviq, approved by the FDA.

Shares in the company were trading 1.3% higher at $4.6 during pre-market trade. Over the past 52 weeks, the company has traded between $3.26 and $7.22.

Meanwhile, coverage of biopharmaceutical company Vertex Pharmaceuticals Incorporated ( VRTX ) has been initiated by analysts at Canaccord Genuity with a buy rating and a price target of $150 a share.

Shares in the company were trading 1.1% higher at $126.97 during pre-market trading . Over the past 52 weeks, the company has traded between $59.79 and $136.33.

And ANI Pharmaceuticals ( ANIP ), a specialty pharmaceutical company, has been downgraded by analysts at Roth Capital Partners to a neutral rating from a buy. The firm set its price target on the stock at $78 a share.

Shares in the company were unchanged at $69.57 during pre-market trading. Over the past 52 weeks, the company has traded between $19.90 and $71.78.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

VRTX ARNA ANIP

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More